Determining the Relationships of Different Global Disclosure Requirements

This webinar happened on 03 May, 2017
Dont worry if you missed it, we have it recorded for you.

Pharma transparency is the future. How well are we prepared? In this webinar, qordata has invited an industry expert to share his analysis of what the efforts of EFPIA, Open Payments and private-sector have yielded in the direction of transparency and disclosure. It concludes with recommendations for improving processes within some of these organizations.

Takeaway From This Webinar:

  • Overview of EFPIA Disclosure Code
  • Impact of the Transparency Movement—individual company and country cases
  • Forms of disclosure/publication
  • Disclosure by country—the case of Germany, UK, the Netherlands and USA (Open Payments Data)


This webinar dissects the specific disclosure requirements of pharma transparency efforts in markets within Europe and the USA. Participants are expected to learn from the presenter’s analysis of transparency bodies in Germany, the Netherlands and UK, and debating the pros and cons of each.

Who Should Attend?

Senior and mid-level Transparency, Corporate Compliance and Legal Professionals from the pharmaceutical manufacturing industry in Europe.


Dr. Klaus Geldsetzer
Chief Compliance Officer EMEA
Santen GmbH

Co-Speaker & Moderator

Ravissh Hasan
Digital Marketing Manager